NCT02593123 2023-01-23
Adoptive Immunotherapy in Relapsed Hematological Malignancy: Early GVHD Prophylaxis
Virginia Commonwealth University
Phase 2 Completed
Virginia Commonwealth University
Dartmouth-Hitchcock Medical Center
Washington University School of Medicine
Beth Israel Deaconess Medical Center